Checkpoint Control and Cancer
Total Page:16
File Type:pdf, Size:1020Kb
Oncogene (2012) 31, 2601–2613 & 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12 www.nature.com/onc REVIEW Checkpoint control and cancer RH Medema1,3 and L Macu˚rek2 1Department of Medical Oncology, University Medical Center, Utrecht, The Netherlands and 2Department of Genome Integrity, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic DNA-damaging therapies represent the most frequently efficient DNA repair has been recently reviewed used non-surgical anticancer strategies in the treatment of extensively elsewhere (Bekker-Jensen and Mailand, human tumors. These therapies can kill tumor cells, but at 2010; Ciccia and Elledge, 2010; Polo and Jackson, the same time they can be particularly damaging and 2011). This review will focus on the mechanisms that mutagenic to healthy tissues. The efficacy of DNA- activate checkpoints after genotoxic stress and silencing damaging treatments can be improved if tumor cell death of checkpoints during the recovery process that can is selectively enhanced, and the recent application of poly- occur after successful repair of the damage. (ADP-ribose) polymerase inhibitors in BRCA1/2-deficient tumors is a successful example of this. DNA damage is known to trigger cell-cycle arrest through activation of Activation of DNA-damage checkpoints DNA-damage checkpoints. This arrest can be reversed once the damage has been repaired, but irreparable In general, activation of DNA-damage checkpoints is damage can promote apoptosis or senescence. Alterna- enabled by recognition of DNA damage by sensors, tively, cells can reenter the cell cycle before repair has followed by an ordered activation of upstream and been completed, giving rise to mutations. In this review we effector kinases, the latter of which can directly target discuss the mechanisms involved in the activation and the major cell-cycle control machinery (Figure 1a). inactivation of DNA-damage checkpoints, and how the DNA damage can induce a cell-cycle arrest in the G1, transition from arrest and cell-cycle re-entry is controlled. intra-S or G2 phase of the cell cycle. Depending on the In addition, we discuss recent attempts to target the phase of the cell cycle when damage occurs, and the checkpoint in anticancer strategies. mode of DNA damage, cells can activate distinct Oncogene (2012) 31, 2601–2613; doi:10.1038/onc.2011.451; pathways in response to genotoxic stress. published online 3 October 2011 The primary response to DNA damage is accom- plished by upstream kinases of the phosphatidylinositol- Keywords: DNA damage; checkpoint; cancer; check- 3-OH kinase-related family, which includes ATM point recovery (ataxia teleangiectasia mutated kinase), ATR (ATM- and Rad3-related kinase) and DNA-PK (DNA-depen- dent protein kinase). Whereas ATM and DNA-PK are activated by double-strand breaks (DSBs), ATR re- Introduction sponds to a broader spectrum of DNA-damaging lesions that generate single-stranded DNA (including stalled To maintain genome integrity, cells need to adequately replication forks caused by bulky base adducts or UV respond to various modes of genotoxic stress. This is photoproducts). This simplistic view, however, is in fact achieved by activation of evolutionarily conserved more complex because DSBs are processed during the DNA-damage response (DDR) pathways that abrogate S/G2 phases of the cell cycle by the endonuclease CtIP cell-cycle progression when the genome is damaged and and generate single-stranded DNA lesions leading to a stimulate DNA repair. Depending on the extent of secondary activation of the ATR (Jazayeri et al., 2006; DNA damage, cells either manage to repair all lesions Sartori et al., 2007). All phosphatidylinositol-3-OH and re-enter the cell cycle (checkpoint recovery), or they kinases responding to DNA damage show similar are eliminated by programmed cell death (apoptosis). substrate specificities, and recent phosphoproteomic Alternatively, cells can remain permanently arrested screens reveal a substantial overlap of their substrates after a DNA-damaging insult (senescence). Activation (Matsuoka et al., 2007; Bennetzen et al., 2010; Bensimon of the components of DDR pathway that allows et al., 2010). The best example is probably the histone variant H2AX, which is rapidly phosphorylated at Correspondence: Dr L Macu˚rek, Department of Genome Integrity, Ser-139 (producing gH2AX) by ATM/ATR or DNA-PK Institute of Molecular Genetics, Academy of Sciences of the Czech in the chromatin flanking the damage site. On the other Republic, Videnska 1083, Prague 4 14200, Czech Republic. hand, these kinases also have some exclusive substrates, E-mail: [email protected] which are not shared by the other members. Thus ATM 3Current address: Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands phosphorylates checkpoint kinase-2 (Chk2) at Thr-68, Received 10 July 2011; revised 16 August 2011; accepted 29 August 2011; whereas ATR phosphorylates Chk1 at two residues, published online 3 October 2011 Ser-317 and Ser-345 (Bartek and Lukas, 2003). In general, Checkpoint control and cancer RH Medema and L Macu˚rek 2602 IR or chemotherapy UV or replication stress (Falck et al., 2005). Active ATM generates gH2AX at the surrounding chromatin, which is recognized by DSB ssDNA CtIP (S or G2 phase) RPA phosphopeptide-binding BRCT domains that are present MRN 9-1-1 H2AX ATRIP in many proteins involved in the DDR, and serves as a MDC1 TopBP1 docking site for a large adaptor protein, MDC1 (Stucki RHINO et al., 2005). Recruitment of multiple additional compo- ATM ATR p38 nents of the checkpoint then follows in an orderly Claspin Chk2 Mdm2 manner, including RNF8, RNF168, HERC2, 53BP1 and MK2 Chk1 BRCA1 (reviewed elsewhere Bekker-Jensen and Mai- p53 land, 2010). In general, recruitment of these proteins to Nek11 the chromatin is essential for efficient DNA repair and Bax GADD45 p21 Cdc25A/B/C Wee1 may also have some role in further amplification of the Noxa checkpoint signaling (that is, by recruiting more ATM) (Lee et al., 2010; Shibata et al., 2010). ATM is rapidly cyclin autophosphorylated at Ser-1981, which was originally APOPTOSIS Cdk proposed to induce the dissociation of an inactive CHECKPOINT MAINTENANCE homodimer into active monomers (Bakkenist and & SURVIVAL CHECKPOINT ARREST Kastan, 2003). However, mice lacking the corresponding ATM autophosphorylation sites are still able to fully Aurora-A activate the checkpoint after exposure to ionizing H2AX hBora radiation (IR), strongly suggesting that ATM autopho- ATM sphorylation is not an essential step for its activation Plk1 (but a useful marker of ATM activity) (Pellegrini et al., Mdm2 Wip1 MdmX 2006). Instead, DNA damage-induced acetylation of ATR ATM at Lys-3016 by the acetyltransferase Tip60 was Claspin recently proposed to activate the ATM (Sun et al., 2005, 2007). In this model, Tip60 is recruited to DSBs by a GTSE1 p53 Chk1 direct interaction with the Mre11–Rad50–Nbs1 complex and its enzymatic activity toward ATM is increased after binding of its chromodomain to trimethylated histone p21 Cdc25A/B/C Wee1 H3 (H3K9me3) (Sun et al., 2009; Chailleux et al., 2010). By contrast, single-stranded DNA lesions (such as the cyclin B stalled replication forks or resected DSBs) are rapidly Cdk1 coated by replication protein-A complexes, which further recruit and activate ATR in a stable complex CHECKPOINT RECOVERY with its cofactor ATRIP (Zou and Elledge, 2003). In parallel, replication protein-A binds to Rad17 and Figure 1 (a) Checkpoint activation. DNA damage is recognized by various sensor and adaptor proteins, which leads to activation of recruits a ring-shaped trimeric complex, Rad9–Hus1– ATM and ATR kinases and allows establishing of a DNA-damage Rad1 (9-1-1), to the site of damage. This 9-1-1 complex checkpoint. The major components activated during this response is then phosphorylated by ATR and can bind to the are Chk1 and p53 (green). Chk1 regulates cdc25A/B/C and Wee1, BRCT domains of an adaptor protein, TopBP1, which which leads to inhibitory phosphorylation of Cdk (yellow dots), further boosts the activity of ATR (Cimprich and prevents its activation (red) and causes cell-cycle arrest. p53 is stabilized by multiple posttranslational modifications (dots), and by Cortez, 2008). RHINO, a recently identified 9-1-1- and increasing the transcription of a Cdk inhibitor, p21, and repressing TopBP1-interacting protein, is required for efficient the transcription of cyclin-B, it contributes to inhibition of cyclin– activation of ATR (Cotta-Ramusino et al., 2011). Active Cdk. In addition, cells activate the Chk2 and p38/MK2 pathways ATR has several hundreds of substrates, including that are involved in apoptosis and checkpoint maintenance, Chk1, which is essential for induction of the checkpoint respectively. (b) Recovery from the G2 checkpoint. After DNA repair, multiple proteins are de-phosphorylated by Wip1 phospha- response. Importantly, Chk1 needs to form a complex tase, which leads to silencing of the checkpoint signaling and with a mediator protein, claspin, to be efficiently inactivation of p53. In parallel, Plk1 kinase targets claspin and activated by ATR (Chini and Chen, 2003; Kumagai Wee1 for degradation, and activates Cdc25A/B/C, which allows et al., 2004). Upon phosphorylation, Chk1 is released activation of cyclin-B–Cdk1 and checkpoint recovery. from the chromatin and can freely diffuse through the nucleus to phosphorylate multiple substrates to establish phosphorylation of Chk2 and Chk1